A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer (Q43055438)
Jump to navigation
Jump to search
scientific article published in June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer |
scientific article published in June 2010 |
Statements
1 reference
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer (English)
1 reference
John D Hainsworth
1 reference
Denise A Yardley
1 reference
Nancy W Peacock
1 reference
Natalie R Dickson
1 reference
Melissa B White
1 reference
Elizabeth R Vázquez
1 reference
John T Foust
1 reference
Richard Grapski
1 reference
Linda K Hendricks
1 reference
William L Scott
1 reference
1 June 2010
1 reference
1 reference
Identifiers
1 reference